Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2024World Journal of Clinical CasesOpen Access

Cytokine release syndrome triggered by programmed death 1 blockade (sintilimab) therapy in a psoriasis patient: A case report

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMinghui ZhouMYMinfeng YeZZZhenxing Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhou et al. (2024) studied this question.

synapsesocial.com/papers/68e643ceb6db6435875d4eabhttps://doi.org/10.12998/wjcc.v12.i18.3555
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy2021 · 65 citations
  2. 2ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells2018 · 3,671 citations
  3. 3Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy2017 · 159 citations
  4. 4Cancer Statistics, 20212021 · 17,452 citations
  5. 5Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors2021 · 55 citations